151 related articles for article (PubMed ID: 35983952)
1. Blinded sample size recalculation in adaptive enrichment designs.
Placzek M; Friede T
Biom J; 2023 Feb; 65(2):e2000345. PubMed ID: 35983952
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies.
Placzek M; Friede T
Stat Methods Med Res; 2018 Nov; 27(11):3286-3303. PubMed ID: 29298604
[TBL] [Abstract][Full Text] [Related]
3. Timing of the interim analysis in adaptive enrichment designs.
Benner L; Kieser M
J Biopharm Stat; 2018; 28(4):622-632. PubMed ID: 29064745
[TBL] [Abstract][Full Text] [Related]
4. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
Herrmann C; Rauch G
Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
[TBL] [Abstract][Full Text] [Related]
5. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
Herrmann C; Pilz M; Kieser M; Rauch G
Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
[TBL] [Abstract][Full Text] [Related]
6. Improving sample size recalculation in adaptive clinical trials by resampling.
Herrmann C; Kluge C; Pilz M; Kieser M; Rauch G
Pharm Stat; 2021 Nov; 20(6):1035-1050. PubMed ID: 33792167
[TBL] [Abstract][Full Text] [Related]
7. Blinded sample size recalculation in clinical trials with binary composite endpoints.
Sander A; Rauch G; Kieser M
J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
[TBL] [Abstract][Full Text] [Related]
8. Sample size re-estimation in adaptive enrichment design.
Lin R; Yang Z; Yuan Y; Yin G
Contemp Clin Trials; 2021 Jan; 100():106216. PubMed ID: 33246098
[TBL] [Abstract][Full Text] [Related]
9. Sample size recalculation based on the prevalence in a randomized test-treatment study.
Hot A; Benda N; Bossuyt PM; Gerke O; Vach W; Zapf A
BMC Med Res Methodol; 2022 Jul; 22(1):205. PubMed ID: 35879675
[TBL] [Abstract][Full Text] [Related]
10. Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.
Kunzmann K; Grayling MJ; Lee KM; Robertson DS; Rufibach K; Wason JMS
Stat Med; 2022 Feb; 41(5):877-890. PubMed ID: 35023184
[TBL] [Abstract][Full Text] [Related]
11. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
Harden M; Friede T
Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
[TBL] [Abstract][Full Text] [Related]
12. Sample size adjustment designs with time-to-event outcomes: A caution.
Freidlin B; Korn EL
Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
[TBL] [Abstract][Full Text] [Related]
13. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Blinded and unblinded internal pilot study designs for clinical trials with count data.
Schneider S; Schmidli H; Friede T
Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
[TBL] [Abstract][Full Text] [Related]
16. Blinded sample size re-estimation for recurrent event data with time trends.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
[TBL] [Abstract][Full Text] [Related]
17. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.
Boessen R; van der Baan F; Groenwold R; Egberts A; Klungel O; Grobbee D; Knol M; Roes K
Pharm Stat; 2013; 12(6):366-74. PubMed ID: 24214896
[TBL] [Abstract][Full Text] [Related]
18. Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths.
Igeta M; Matsui S
Stat Med; 2022 Dec; 41(29):5622-5644. PubMed ID: 36148560
[TBL] [Abstract][Full Text] [Related]
19. Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R.
Friede T; Stallard N; Parsons N
Biom J; 2020 Sep; 62(5):1264-1283. PubMed ID: 32118317
[TBL] [Abstract][Full Text] [Related]
20. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
Friede T; Kieser M
Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
